Table 1.
Main characteristics and clinical outcomes of the overall sample of 1,318 RHD children and stratified according to valve surgery subgroups: isolated mitral valve (MV), isolated aortic valve (AV), and mitral and tricuspid and/or aortic valves (MV + TV and/or AV).
| Patients demographic and clinical characteristics | Total | MV (n = 1,318) | AV | Mitral+TV and/or AV | p-valuea | |
|---|---|---|---|---|---|---|
| (n = 1,318) | (n = 612, 46.4%) | (n = 73, 5.5%) | (n = 633, 48.0%) | |||
| Country: Sudan, | n (%) | 1,039 (78.8) | 459 (75.0) | 66 (90.4) | 514 (81.2) | 0.001 |
| Females, | n (%) | 672 (51.0) | 361 (59.0) | 15 (20.5) | 296 (46.8) | <0.001 |
| Age, | Median, Mean (SDb) | 12.0, 11.1 (2.4) | 11.0, 10.8 (2.6) | 12.0, 11.9 (1.7) | 12.0, 11.4 (2.2) | <0.001 |
| BMI, | Median, Mean (SDb) | 13.2, 13.5 (2.5) | 13.0, 13.5 (2.9) | 14.4, 15.0 (2.3) | 13.2, 13.3 (2.0) | <0.001 |
| Urgency, | n (%) | 185 (14.0) | 66 (10.8) | 4 (5.5) | 115 (18.2) | <0.001 |
| Reoperation, | n (%) | 143 (10.9) | 75 (12.2) | 5 (6.8) | 63 (10.0) | 0.242 |
| Months to reoperation, | Median, Mean (SDb) | 14.5, 24.3 (28.3) | 15, 25.2 (29.9) | 17, 28.0 (31.2) | 12, 22.8 (26.4) | 0.289 |
| <6 | n (%) | 52 (36.6) | 30 (40.0) | 1 (20.0) | 21 (33.9) | 0.578 |
| 6–24 | n (%) | 40 (28.2) | 17 (22.7) | 2 (40.0) | 21 (33.9) | |
| >24 | n (%) | 50 (35.2) | 28 (37.3) | 2 (40.0) | 20 (32.3) | |
| In-hospital or 30-days mortality, | n, % [95%CI] | 47, 3.6 [2.6–4.7] | 17, 2.8 [1.6–4.4] | 0, 0.0 [0.0–4.9]c | 30, 4.7 [3.2–6.7] | 0.039 |
| In urgent surgeries | n, % [95%CI] | 11, 6.0 [3.0–10.4] | 3, 4.6 [1.0–12.7] | 0, 0.0 [0.0–60.0]c | 8, 7.0 [3.1–13.3] | 0.803 |
| In reoperated patients | n, % [95%CI] | 10, 7.0 [3.4–12.5] | 6, 8.0 [3.0–16.6] | 0, 0.0 [0.0–52.3]c | 4, 6.3 [1.8–15.5] | 0.830 |
EMERGENCY-NGO Salam Centre, Khartoum 2007–2019.
a
Between groups comparison: χ2 test or Fisher exact test, and or ANOVA or Kruskal-Wallis test, depending on variable distribution.
b
SD, Standard Deviation.
c
One-sided 97.5% confidence interval.